Skip to main content Help with accessibility Skip to main navigation

AVATROMBOPAG tablets (Doptelet®▼) for treating severe thrombocytopenia in adults with chronic liver disease having planned invasive procedures

CCG Approval Status:

Date Added: 30 - Jul - 2020
Red

The Pan Mersey Area Prescribing Committee recommends the prescribing of AVATROMBOPAG tablets (Doptelet®▼), by specialists only, for treating severe thrombocytopenia in adults with chronic liver disease having planned invasive procedures in accordance with NICE TA626.